MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
NanoVibronix DPO Ratio 2011-2026 | NAOV
Annual DPO Ratio NanoVibronix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 32.2 | 49.9 | 47.7 | 45.6 | 436 | 189 | 446 | 697 | 340 | 432 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 697 | 32.2 | 271 |
Quarterly DPO Ratio NanoVibronix
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65.2 | 36.1 | 13.6 | - | 22 | 15.1 | 31.1 | - | 39.8 | 45.6 | 42.6 | - | 574 | 77.2 | 71.2 | - | 40.9 | 117 | 432 | - | 258 | 56.9 | 198 | - | 218 | 210 | 565 | - | 383 | 320 | 749 | - | 697 | 852 | 713 | - | 277 | 340 | 237 | - | 529 | 353 | 725 | - | 263 | 369 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 852 | 13.6 | 284 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
61.8 | $ 2.11 | 8.21 % | $ 3.29 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 10.42 | -1.65 % | $ 1.41 B | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Alphatec Holdings
ATEC
|
73.8 | $ 12.6 | 2.61 % | $ 1.89 B | USA |
 |
Butterfly Network
BFLY
|
51.3 | $ 3.91 | 2.62 % | $ 828 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
81.1 | $ 8.38 | -0.24 % | $ 602 M |  Israel |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
Boston Scientific Corporation
BSX
|
61.7 | $ 69.79 | 0.95 % | $ 103 B | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.96 | 1.02 % | $ 148 M |  France |
 |
CONMED Corporation
CNMD
|
57.3 | $ 37.41 | 0.35 % | $ 1.16 B | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Cytosorbents Corporation
CTSO
|
125 | $ 0.65 | -8.13 % | $ 35.4 M | USA |
 |
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
25.8 | $ 11.03 | 2.22 % | $ 298 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Establishment Labs Holdings
ESTA
|
248 | $ 63.48 | 0.21 % | $ 1.88 B |  Costa-rica |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
16.6 | $ 18.42 | 0.22 % | $ 121 M | USA |
 |
InMode Ltd.
INMD
|
72.7 | $ 13.43 | -0.81 % | $ 868 M | Israel |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Abbott Laboratories
ABT
|
79.7 | $ 109.95 | 1.8 % | $ 191 B | USA |
 |
Delcath Systems
DCTH
|
56 | $ 9.81 | 3.81 % | $ 351 M | USA |
 |
Bio-Rad Laboratories
BIO
|
41 | $ 261.24 | -0.59 % | $ 7.37 B | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 2.19 | 3.79 % | $ 1.33 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 9.01 | -2.49 % | $ 694 M | USA |
 |
AxoGen
AXGN
|
34.4 | $ 32.84 | 1.55 % | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
33.7 | $ 169.45 | 3.18 % | $ 12.7 B | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 32.76 | -2.93 % | $ 4.88 K | USA |
 |
IRIDEX Corporation
IRIX
|
50.7 | $ 1.33 | 2.31 % | $ 21.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
52.3 | $ 3.67 | 1.1 % | $ 151 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 17.11 | -1.16 % | $ 401 M | USA |
 |
Integer Holdings Corporation
ITGR
|
28.9 | $ 84.12 | 1.34 % | $ 2.92 B | USA |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |
 |
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | USA |